The DOI matches its Crossref record; 183 of the 186 references it cites were found in a registry or an index.
Nicotinic receptors in human brain: topography and pathology
Open accessAbstract
Brain nicotinic acetylcholine receptors (nAChR) are a class of ligand-gated channels composed of alpha and beta subunits with specific structural, functional and pharmacological properties. They participate in the physiological and behavioural effects of acetylcholine and mediate responses to nicotine. They are associated with numerous transmitter systems and their expression is altered during development and ageing as well as in diseases such as autism, schizophrenia, Alzheimer's disease, Parkinson's disease and Lewy body dementia. Nicotinic receptors containing a number of different subunits are highly expressed during early human development. Disorders believed to be associated with abnormal brain maturation involve deficits in both alpha4beta2, in the case of autism, and alpha7 possibly in addition to alpha4beta2 nAChRs in the case of schizophrenia. In ageing and age-related neurodegenerative disorders nAChR deficits are predominantly associated with alpha4-containing receptors, although some studies also indicate the involvement of alpha3 and alpha7 subunits. Whilst ageing appears to be associated with reductions in subunit mRNA as well as protein expression, in Alzheimer's disease only protein loss is apparent. Nicotinic therapy may be of benefit in a number of neurological conditions, however studies evaluating further both the distribution of specific subunit involvement and the correlation of nAChR deficits with clinical symptoms are required to inform therapeutic strategy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The heteromeric a4b2* subtype and the homomeric a7 are the most prevalent receptor subtypes in the central nervous system (Court et al., 2000).”
From Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors (2014) · cites this paper as Court et al., 2000
Citations
Cites
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationSELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
A rapid radiochemical method for the determination of choline acetyltransferase
Fonnum, F. (1975) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1975.tb11895.x · Cited by 2,358
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
Frith, U., & Mira, M. P. (1992) · Focus on Autism and Other Developmental Disabilities · doi:10.1177/108835769200700302 · Cited by 900
Research works printed but not linked: 1
- Perry, 1989, Nicotine [3H-nicotine] receptor binding in human brain: characterization and involvement in cholinergic neuropathology, Neurosci. Res. Commun., 5, 117
Cited by
Sorted by citations
Levin, E. D., McClernon, F. J., & Rezvani, A. H. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0164-7 · Cited by 820
Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 678
The dynamic effects of nicotine on the developing brain
Dwyer, J. B., McQuown, S. C., & Leslie, F. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.003 · Cited by 559
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 543
Belmonte, M. K., Cook, E. H., Anderson, G. M., Rubenstein, J. L. R., Greenough, W. T., Beckel-Mitchener, A., Courchesne, E., Boulanger, L. M., Powell, S. B., Levitt, P. R., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001499 · Cited by 442
Self-citationCellular and synaptic mechanisms of nicotine addiction
Mansvelder, H. D., & McGehee, D. S. (2002) · Journal of Neurobiology · doi:10.1002/neu.10148 · Cited by 450
Smoking, nicotine and Parkinson's disease
Quik, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.008 · Cited by 330
Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection.
Egea, J., Buendía, I., Parada, E., Navarro, E., León, R., & López, M. G. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.032 · Cited by 292
Functional brain imaging of tobacco use and dependence
BRODY, A. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.04.012 · Cited by 207
Pimlott, S. L., Piggott, M. A., Owens, J., Greally, E., COURT, J. A., Jaros, E., Perry, R. H., Perry, E. K., & Wyper, D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300302 · Cited by 170
Self-citationA critical review of neonicotinoid insecticides for developmental neurotoxicity
Sheets, L. P., Li, A. A., Minnema, D. J., Collier, R. H., Creek, M. R., & Peffer, R. C. (2015) · Critical Reviews in Toxicology · doi:10.3109/10408444.2015.1090948 · Cited by 159
Nicotine and Parkinson's disease: implications for therapy
Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders · doi:10.1002/mds.21900 · Cited by 154
Nicotinic–serotonergic interactions in brain and behaviour
Seth, P., Cheeta, S., Tucci, S., & File, S. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00715-8 · Cited by 145
Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors
Bertrand, D., Lee, C., Flood, D. G., Marger, F., & Donnelly‐Roberts, D. L. (2015) · Pharmacological Reviews · doi:10.1124/pr.113.008581 · Cited by 142
Acetylcholinesterase and Butyrylcholinesterase – Important Enzymes of Human Body
Patočka, J., Kuča, K., & Jun, D. (2004) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2018.95 · Cited by 137
Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson’s Disease Therapy
Quik, M., & McIntosh, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094375 · Cited by 129
Gotti, C., Moretti, M., Bohr, I., Ziabreva, I., Vailati, S., Longhi, R., Riganti, L., Gaimarri, A., McKeith, I., Perry, R., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.005 · Cited by 137
Self-citationFunction of Partially Duplicated Human α7 Nicotinic Receptor Subunit CHRFAM7A Gene
de Lucas‐Cerrillo, A. M., Maldifassi, M. C., Arnalich, F., Renart, J., Atienza, G., Serantes, R., Cruces, J., Sánchez‐Pacheco, A., Andrés‐Mateos, E., & Montiel, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180067 · Cited by 123
Alzheimer's disease and anaesthesia: implications for the central cholinergic system
Fodale, V., Quattrone, D., Trecroci, C., Caminiti, V., & Santamaria, L. B. (2006) · British Journal of Anaesthesia · doi:10.1093/bja/ael233 · Cited by 121
Nicotinic receptors as CNS targets for Parkinson's disease.
Quik, M., Bordia, T., & O'Leary, K. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.015 · Cited by 119
Brunzell, D. H., & McIntosh, J. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.299 · Cited by 114
Kimes, A. S., Horti, A. G., London, E. D., Chefer, S. I., Contoreggi, C. S., Ernst, M., Friello, P. J., Koren, A. O., Kurian, V., Matochik, J. A., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0492fje · Cited by 114
Romanelli, M. N., & Gualtieri, F. (2003) · Medicinal Research Reviews · doi:10.1002/med.10037 · Cited by 112
Kawamata, J., & Shimohama, S. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110173 · Cited by 111
Nicotinic actions on neuronal networks for cognition: General principles and long-term consequences
Poorthuis, R. B., Goriounova, N. A., Couey, J. J., & Mansvelder, H. D. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.031 · Cited by 102
Alpha7 nicotinic acetylcholine receptor: A link between inflammation and neurodegeneration
Conejero‐Goldberg, C., Davies, P., & Ulloa, L. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.10.007 · Cited by 101
Developmental Excitation of Corticothalamic Neurons by Nicotinic Acetylcholine Receptors
Kassam, S. M., Herman, P. M., Goodfellow, N. M., Alves, N. C., & Lambe, E. K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2645-08.2008 · Cited by 100
Han, Z., Zoli, M., Cardona, A., Bourgeois, J., Changeux, J., & Novère, N. G. L. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10659 · Cited by 102
Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models
Shimohama, S. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.332 · Cited by 102
In vivo Brain Imaging of Human Exposure to Nicotine and Tobacco
Sharma, A., & Brody, A. L. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_6 · Cited by 90
Ding, Y., Fowler, J. S., Logan, J., Wang, G., Telang, F., Garza, V., Biegon, A. R., Pareto, D., Rooney, W. D., Shea, C. E., et al. (2004) · Synapse · doi:10.1002/syn.20051 · Cited by 91
Scientific Opinion on the developmental neurotoxicity potential of acetamiprid and imidacloprid
(PPR), E. P. O. P. P. P. A. T. R. (2013) · EFSA Journal · doi:10.2903/j.efsa.2013.3471 · Cited by 97
Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes
Turner, J. R., & Kellar, K. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2112-05.2005 · Cited by 89
The role of astrocytic α7 nicotinic acetylcholine receptors in Alzheimer disease
Fontana, I. C., Kumar, A., & Nordberg, A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00792-4 · Cited by 86
Quik, M., Vailati, S., Bordia, T., Kulak, J. M., Fan, H., McIntosh, J. M., Clementi, F., & Gotti, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006015 · Cited by 86
Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum
Graham, A., COURT, J. A., Martin-Ruiz, C. M., Jaros, E., Perry, R., Volsen, S. G., Bose, S., Evans, N. M., Ince, P. G., Kuryatov, A., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00223-3 · Cited by 85
Self-citationDifferential nicotinic acetylcholine receptor subunit expression in the human hippocampus
Graham, A. J., Ray, M. A., Perry, E. K., Jaros, E., Perry, R. H., Volsen, S. G., Bose, S., Evans, N. M., Lindstrom, J. M., & COURT, J. A. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(02)00100-x · Cited by 85
Self-citationQuik, M., Sum, J., Whiteaker, P., McCallum, S. E., Marks, M. J., Musachio, J. L., McIntosh, J. M., Collins, A. C., & Grady, S. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1169 · Cited by 86
Falk, L. L., Nordberg, A. K., Seiger, Å., Kjældgaard, A., & Hellström‐Lindahl, E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.049 · Cited by 82
Huey, R., Hawthorne, S. J., & McCarron, P. A. (2016) · Journal of drug targeting · doi:10.1080/1061186x.2016.1223676 · Cited by 77
Cyto- and receptor architectonic mapping of the human brain
Palomero‐Gallagher, N., & Zilles, K. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00024-4 · Cited by 74
Wong, D. F., Kuwabara, H., Pomper, M. G., Holt, D. P., Brašić, J. R., George, N., Фролов, Б. А., Willis, W. D., Gao, Y., Valentine, H., et al. (2014) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0779-3 · Cited by 74
O'Brien, J. T., Colloby, S. J., Pakrasi, S., Perry, E. K., Pimlott, S. L., Wyper, D., McKeith, I. G., & Williams, E. D. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.108209 · Cited by 74
Self-citationLifetime cigarette smoking is associated with striatal volume measures
Das, D., Cherbuin, N., Anstey, K. J., Sachdev, P. S., & Easteal, S. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00301.x · Cited by 75
Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia
Wallace, T. L., & Bertrand, D. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.736498 · Cited by 73
Inattentiveness, parental smoking and adolescent smoking initiation
Barman, S. K., Pulkkinen, L., Kaprio, J. A., & Rose, R. J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00789.x · Cited by 72
Loss of α‐conotoxinMII‐ and A85380‐sensitive nicotinic receptors in Parkinson's disease striatum
Quik, M., Bordia, T., Forno, L. S., & McIntosh, J. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02177.x · Cited by 62
The potential role of cotinine in the cognitive and neuroprotective actions of nicotine
Buccafusco, J. J., & Terry, A. V. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00226-1 · Cited by 62
Nicotinic receptor subtypes in human brain related to aging and dementia
Perry, E. K., Martin-Ruiz, C. M., & COURT, J. A. (2001) · Alcohol · doi:10.1016/s0741-8329(01)00130-6 · Cited by 62
Self-citationPET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders
Tiepolt, S., Meyer, P., Patt, M., Deuther‐Conrad, W., Hesse, S., Barthel, H., & Sabri, O. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263198 · Cited by 61
Oikawa, H., Nakamichi, N., Kambe, Y., Ogura, M., & Yoneda, Y. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20398 · Cited by 59
Rasch, B., Gais, S., & Born, J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.6 · Cited by 57
Effects of nicotine and mecamylamine on cognition in rhesus monkeys
Katner, S. N., Davis, S. A., Kirsten, A. J., & Taffe, M. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1804-z · Cited by 58
Teaktong, T., Graham, A. J., COURT, J. A., Perry, R. H., Jaros, E., Johnson, M., Hall, R., & Perry, E. K. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.06.015 · Cited by 57
Self-citationThe role of cortical cholinergic pre- and post-synaptic receptors in taste memory formation
Ramı́rez-Lugo, L., Miranda, M. I., Escobar, M. L., Espinosa, E., & Bermúdez‐Rattoni, F. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(02)00038-2 · Cited by 55
Yoo, J. H., Valdovinos, M. G., & Williams, D. C. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0322-8 · Cited by 53
Kulak, J. M., Sum, J., Musachio, J. L., McIntosh, J. M., & Quik, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00868.x · Cited by 53
Aliev, G., Li, Y., Palacios, H. H., & Obrenovich, M. E. (2011) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/157489011797376942 · Cited by 51
In SilicoModels for the Human α4β2 Nicotinic Acetylcholine Receptor
Haddadian, E. J., Cheng, M. H., Coalson, R. D., Xu, Y., & Tang, P. S. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp804868s · Cited by 48
Alzheimer’s Disease and Genetics of Inflammation: A Pharmacogenomic Vision
Vasto, S., Candore, G., Duro, G., Lio, D., Grimaldi, M. P., & Caruso, C. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.12.1735 · Cited by 46
Luhar, R. B., Sawyer, K. S., Gravitz, Z. R., Ruiz, S. M., & Oscar‐Berman, M. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s52298 · Cited by 43
Kulak, J. M., Musachio, J. L., McIntosh, J. M., & Quik, M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039347 · Cited by 43
Higher expression of α7 nicotinic acetylcholine receptors in human fetal compared to adult brain
Falk, L. L., Nordberg, A. K., Seiger, Å., Kjældgaard, A., & Hellström‐Lindahl, E. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(03)00063-4 · Cited by 42
Acetylcholinesterase inhibitors may improve myelin integrity
Bartzokis, G. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.020 · Cited by 41
Brunzell, D. H., McIntosh, J. M., & Papke, R. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12421 · Cited by 43
Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands.
Pomper, M. G., Phillips, E. D., Fan, H. S., McCarthy, D. J., Keith, R. A., Gordon, J. C., Scheffel, U., Dannals, R. F., & Musachio, J. L. (2005) · PubMed · Cited by 41
Suzuki, T., Ueta, K., Sugimoto, M., Uchida, I., & Mashimo, T. (2003) · Anesthesia & Analgesia · doi:10.1097/00000539-200302000-00028 · Cited by 39
Hung, S., Huang, W., Liou, H., & Fu, W. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.003 · Cited by 39
Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET
Mitkovski, S., Villemagne, V. L., Novakovic, K. E., O'Keefe, G. J., Tochon‐Danguy, H., Mulligan, R. S., Dickinson, K. L., Saunder, T., Grégoire, M., Bottlaender, M., et al. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.04.013 · Cited by 39
Microarray Technology and its Application on Nicotine Research
Li, M. D., Konu, Ö., Kane, J. K., & Becker, K. G. (2002) · Molecular Neurobiology · doi:10.1385/mn:25:3:265 · Cited by 38
Löscher, W., Potschka, H., Właź, P., Danysz, W., & Parsons, C. G. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01542-5 · Cited by 38
Horti, A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.030 · Cited by 33
Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease
Hirao, K., Pontone, G. M., & Smith, G. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.010 · Cited by 38
Coughlin, J. M., Du, Y., Rosenthal, H. B., Slania, S., Koo, S. M., Park, A., Solomon, G., Vranešić, M., Antonsdottir, I. M., Speck, C. L., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.10.009 · Cited by 37
Deuther-Conrad, W., Fischer, S., Hiller, A., Becker, G., Cumming, P., Xiong, G., Funke, U., Sabri, O., Peters, D., & Brust, P. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1808-y · Cited by 35
Scientific Opinion on the developmental neurotoxicity potential of acetamiprid and imidacloprid
Ockleford, C. (2013) · Cited by 36
COURT, J. A., Johnson, M., Religa, D., Keverne, J., Kalaria, R. N., Jaros, E., McKeith, I. G., Perry, R., Näslund, J., & Perry, E. K. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00674.x · Cited by 36
Self-citationIn vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer’s Disease
Nakaizumi, K., Ouchi, Y., Terada, T., Yoshikawa, E., Kakimoto, A., Isobe, T., Bunai, T., Yokokura, M., Suzuki, K., & Magata, Y. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170591 · Cited by 35
iPSC model of CHRFAM7A effect on α7 nicotinic acetylcholine receptor function in the human context
Ihnatovych, I., Nayak, T. K., Ouf, A., Süle, N., Birkaya, B. G., Chaves, L. D., Auerbach, A. L., & Szigeti, K. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0375-z · Cited by 34
Toyohara, J., Ishiwata, K., Sakata, M., Wu, J., Nishiyama, S., Tsukada, H., & Hashimoto, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008961 · Cited by 34
Neuronal α7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia
Wallace, T. L., & Bertrand, D. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.08.003 · Cited by 37
Machaalani, R., Kashi, P. K., & Waters, K. A. (2010) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2010.05.009 · Cited by 32
Gmehlin, D., Kreisel, S. H., Bachmann, S., Weisbrod, M., & Thomas, C. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr067 · Cited by 32
Ogawa, M., Nishiyama, S., Tsukada, H., Hatano, K., Fuchigami, T., Yamaguchi, H., Matsushima, Y., Ito, K., & Magata, Y. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.11.007 · Cited by 31
Neurochemistry of consciousness: cholinergic pathologies in the human brain
Perry, E. K., & Perry, R. H. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45020-6 · Cited by 31
Self-citationNMR structure of the transmembrane domain of the n-acetylcholine receptor β2 subunit
Bondarenko, V., Tillman, T. S., Xu, Y., & Tang, P. S. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.04.014 · Cited by 31
In Vitro Imaging Techniques in Neurodegenerative Diseases
Långström, B., Andrén, P. E., Lindhe, Ö., Svedberg, M. M., & Hall, H. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0088-1 · Cited by 30
Shimohama, S., & Kawamata, J. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1_8 · Cited by 33
Yohn, N. L., Turner, J. R., & Blendy, J. A. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211706 · Cited by 28
Cholinergic system in schizophrenia: A systematic review and meta-analysis
Saint-Georges, Z., MacDonald, J., Al-Khalili, R., Hamati, R., Solmi, M., Keshavan, M. S., Tuominen, L. J., & Guimond, S. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03023-y · Cited by 32
Taslim, N., Al-Rejaie, S. S., & Dar, M. S. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.046 · Cited by 28
Kulak, J. M., & Schneider, J. S. (2004) · Brain Research · doi:10.1016/j.brainres.2003.10.062 · Cited by 28
Tanibuchi, Y., Wu, J., Toyohara, J., Fujita, Y., Iyo, M., & Hashimoto, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.008 · Cited by 27
Impact of ageing on postsynaptic neuronal nicotinic neurotransmission in auditory thalamus
Sottile, S. Y., Ling, L. L., Cox, B. C., & Caspary, D. M. (2017) · The Journal of Physiology · doi:10.1113/jp274467 · Cited by 27
Tae, H., & Adams, D. J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106747 · Cited by 27
Smoking Cessation in Patients With Psychiatric Disorders
Gelenberg, A. J., de León, J., Evins, A. E., Parks, J., & Rigotti, N. A. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0109 · Cited by 26
Differential nicotinic receptor expression in monkey basal ganglia: Effects of nigrostriatal damage
Quik, M., Polonskaya, Y., McIntosh, J. M., & Kulak, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00106-9 · Cited by 25
Liu, Q., Yu, K., Chang, Y., Lukas, R. J., & Wu, J. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00760.x · Cited by 25
Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer’s Disease
Lao, K., Zhang, R., Luan, J., Zhang, Y., & Gou, X. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200851 · Cited by 25
Arjmandi-Rad, S., Nieland, J. D., Goozee, K. G., & Vaseghi, S. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07114-y · Cited by 26
Metadata
- Authors
- Court, J. A., Martin-Ruiz, C., Graham, A., & Perry, E.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Court, Jenny A.
- ORCID
- Martin-Ruiz, Carmen
- Venue
- Journal of Chemical Neuroanatomy
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 20
- Issue
- 3-4
- Pages
- 281-298
- ISSN
- 0891-0618 (ISSN-L)
- OpenAlex
- W1967131207
- Cited by
- 180
- References
- 186
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 9 · 2017: 2 · 2016: 6 · 2015: 8 · 2014: 5 · 2013: 6 · 2012: 8
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Journal of Chemical Neuroanatomy (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Eli Lilly and Company
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, human brain, receptor subunit expression, alpha4beta2 nAChR, alpha7 nAChR, brain development, brain aging, neurodegeneration, autism spectrum disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies
- MeSH terms
- Brain Chemistry, Brain Diseases, Humans, Receptors, Nicotinic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review